Robinhood Markets enters its July 29 earnings window with a sharp internal contradiction: the Street is racing to raise targets, while the CEO is selling stock at nearly every price point the rally has offered.
The analyst upgrade cycle has been relentless. Morgan Stanley lifted its target from $95 to $124 on July 10, maintaining Equal-Weight — a meaningful move even from the sidelines. Barclays pushed to $122 from $82 just a day earlier, keeping Overweight. Goldman Sachs raised to $121 from $108 late June, also maintaining Buy. Mizuho is the most aggressive bull, targeting $130. The consensus mean now sits at roughly $117, fractionally above the current price of $111.97. What's notable is the direction of travel: virtually every firm that has touched the name in the past two weeks has moved their target up, not down. The analyst recommendation differential factor ranks in the 99th percentile — as bullish a Street setup as you'll find. EPS momentum over the past 30 days ranks in the 96th percentile to match.
The insider picture cuts the other way. CEO Vladimir Tenev sold more than 356,000 shares on July 6 alone, across multiple tranches priced between $113 and $118, generating roughly $28 million in proceeds. The Chief Legal Officer sold another 3,800 shares the same day. Net insider activity over the past 90 days still shows a positive share count — driven by earlier equity grants — but the dollar flow is overwhelmingly one-directional: insiders have collectively realised over $75 million in value. Tenev's remaining stake of around 54.5 million shares still keeps him deeply aligned, but the pace of selling into a 34% one-month rally is a data point bulls will have to sit with.
Short positioning has stabilised after weeks of rebuilding. Short interest reached 5.1% of the free float by July 9 — up just under 1% on the week — a noticeable deceleration from the sharper climbs of mid-to-late June, when SI jumped from roughly 35.5 million shares to nearly 40.4 million over a three-week stretch. The borrow market remains completely uncrowded. Availability is running at over 1,100% — more than eleven shares available to lend for every one currently short — and the cost to borrow is a negligible 0.48%. Short sellers face zero friction. The ORTEX short score has drifted up to 38.3, still a moderate reading that sits in the 41st percentile for the sector. Options are similarly relaxed: the put/call ratio of 0.63 is almost exactly in line with its 20-day average, with a z-score near zero. There is no signal of options-market alarm heading into earnings.
The earnings history is what gives the July 29 date its edge. The last two Q-results produced meaningful negative moves: the most recent print triggered an 8.7% one-day drop and a 7.7% five-day decline; the print before that fell 15.2% on the day and 8.2% over the following week. The stock has not rewarded holders who held into results in either of the past two cycles. Valuation has expanded alongside the rally — the P/E has risen more than 11 points over the past 30 days to just over 45x, and price-to-book has climbed nearly 2.8 points to 9.6x. The bull case rests on product diversification — AI features, Trump Accounts, the BNY and TradePMR partnerships — while bears flag that an expanding valuation multiple ahead of a print with a recent history of sharp post-earnings declines is a difficult setup to hold through.
The tension to watch into July 29 is whether the analyst target-raise cycle has already pulled forward the good news, leaving the stock priced for a beat that the earnings history suggests it rarely delivers cleanly.
See the live data behind this article on ORTEX.
Open HOOD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
